Power3 Medical Launches BC-SeraPro, the First Proteomics-Based Blood Serum Diagnostic Test for Breast Cancer

HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB: PWRM), has signed its first distribution agreement to provide BC-SeraPro™, its breast cancer blood serum diagnostic test, in twelve Middle Eastern countries before the end of 2007. The agreement with Financial Advisory House’s Medical Equipment Suppliers division (FAH), a Bahrain-based medical instrument distribution company, allows for the marketing and distribution of the BC-SeraPro breast cancer diagnostic test in: Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia, Oman, Qatar, Syria, United Arab Emirates, and Yemen.

MORE ON THIS TOPIC